Publicaciones en las que colabora con Luis Alberto González Guijarro (24)

2022

  1. Chronic Venous Disease in Pregnant Women Causes an Increase in ILK in the Placental Villi Associated with a Decrease in E-Cadherin

    Journal of Personalized Medicine, Vol. 12, Núm. 2

  2. Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity

    Biomedicines, Vol. 10, Núm. 3

2017

  1. Infliximab therapy reverses the increase of allograft inflammatory factor-1 in serum and colonic mucosa of rats with inflammatory bowel disease

    Biomarkers, Vol. 22, Núm. 2, pp. 133-144

2014

  1. Effect of Infliximab in oxidised serum albumin levels during experimental colitis

    Biomarkers, Vol. 19, Núm. 8, pp. 693-701

2013

  1. Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1

    Toxicology and Applied Pharmacology, Vol. 272, Núm. 3, pp. 568-578

2012

  1. Is the autophagy induced by thiopurines beneficial or deleterious?

    Current Drug Metabolism, Vol. 13, Núm. 9, pp. 1267-1276

2011

  1. Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma

    World Journal of Gastroenterology, Vol. 17, Núm. 34, pp. 3899-3911

2009

  1. RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-α-induced cell death in hepatocarcinoma cancer cell lines

    Journal of Cellular Biochemistry, Vol. 108, Núm. 6, pp. 1292-1301

2007

  1. Role of insulin receptor substrate-4 in IGF-I-stimulated HEPG2 proliferation

    Journal of Hepatology, Vol. 46, Núm. 6, pp. 1089-1098

2004

  1. Association of adenylate cyclase with an actin-like protein in the human myometrium

    Gynecological Endocrinology, Vol. 18, Núm. 2, pp. 89-96

  2. Azathioprine acts upon rat hepatocyte mitochondria and stress-activated protein kinases leading to necrosis: Protective role of N-acetyl-L-cysteine

    Journal of Pharmacology and Experimental Therapeutics, Vol. 311, Núm. 2, pp. 668-676

2003

  1. Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver

    Hepatology, Vol. 37, Núm. 6, pp. 1461-1469

  2. Solubilization of Adenylyl Cyclase from Human Myometrium in a α s-Coupled Form

    Bioscience Reports, Vol. 23, Núm. 4, pp. 175-186

2002

  1. Pretreatment with FK506 up-regulates insulin receptors in regenerating rat liver

    Hepatology, Vol. 36, Núm. 3, pp. 555-561

  2. Thiopurine methyltransferase activity in a Spanish population sample: Decrease of enzymatic activity in multiple sclerosis patients

    Multiple Sclerosis, Vol. 8, Núm. 3, pp. 243-248

2001

  1. Determination of thiopurine methyltransferase activity in human erythrocytes by high-performance liquid chromatography: Comparison with the radiochemical method

    Therapeutic Drug Monitoring, Vol. 23, Núm. 5, pp. 536-541

2000

  1. Expression of vasoactive intestinal peptide (VIP) receptors in human uterus

    Peptides, Vol. 21, Núm. 9, pp. 1383-1388

  2. Impairment of adenylate cyclase activity and G-proteins in human uterine leiomyoma

    Tissue and Cell, Vol. 32, Núm. 5, pp. 399-404

1998

  1. Cyclosporin A induces apoptosis in rat hepatocytes in culture

    Archives of Toxicology, Vol. 72, Núm. 9, pp. 559-565

  2. Inhibitory effect of cyclosporin A peptide on rat hepatocytes proliferation induced by mitogens

    Peptides, Vol. 19, Núm. 3, pp. 427-435